328 related articles for article (PubMed ID: 25917329)
1. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a.
Wang S; Song K; Srivastava R; Dong C; Go GW; Li N; Iwakiri Y; Mani A
FASEB J; 2015 Aug; 29(8):3436-45. PubMed ID: 25917329
[TBL] [Abstract][Full Text] [Related]
2. The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome.
Abou Ziki MD; Mani A
Nutr Res; 2019 Oct; 70():18-25. PubMed ID: 30049588
[TBL] [Abstract][Full Text] [Related]
3. The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue.
Go GW; Srivastava R; Hernandez-Ono A; Gang G; Smith SB; Booth CJ; Ginsberg HN; Mani A
Cell Metab; 2014 Feb; 19(2):209-20. PubMed ID: 24506864
[TBL] [Abstract][Full Text] [Related]
4. Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis.
Go GW
Nutrients; 2015 Jun; 7(6):4453-64. PubMed ID: 26046396
[TBL] [Abstract][Full Text] [Related]
5. The LRP6 functional mutation rs2302685 contributes to individual susceptibility to alcoholic liver injury related to the Wnt/β-catenin-TCF1-CYP2E1 signaling pathway.
Xu Y; Chen D; Lin XX; Zhao Q; Guo J; Chen LJ; Zhang W; Xiao J; Lian GH; Peng SF; Guo D; Yang H; Obianom O; Shu Y; Chen Y
Arch Toxicol; 2019 Jun; 93(6):1679-1695. PubMed ID: 30976847
[TBL] [Abstract][Full Text] [Related]
6. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
7. LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation.
Chen J; Yan H; Ren DN; Yin Y; Li Z; He Q; Wo D; Ho MS; Chen Y; Liu Z; Yang J; Liu S; Zhu W
Cell Signal; 2014 May; 26(5):1068-74. PubMed ID: 24412751
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease.
Koeck ES; Iordanskaia T; Sevilla S; Ferrante SC; Hubal MJ; Freishtat RJ; Nadler EP
J Surg Res; 2014 Dec; 192(2):268-75. PubMed ID: 25086727
[TBL] [Abstract][Full Text] [Related]
9.
Chen LJ; Lin XX; Guo J; Xu Y; Zhang SX; Chen D; Zhao Q; Xiao J; Lian GH; Peng SF; Guo D; Yang H; Shu Y; Zhou HH; Zhang W; Chen Y
Int J Biol Sci; 2021; 17(14):3936-3953. PubMed ID: 34671210
[No Abstract] [Full Text] [Related]
10. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals.
Cheng SL; Ramachandran B; Behrmann A; Shao JS; Mead M; Smith C; Krchma K; Bello Arredondo Y; Kovacs A; Kapoor K; Brill LM; Perera R; Williams BO; Towler DA
Circ Res; 2015 Jul; 117(2):142-56. PubMed ID: 26034040
[TBL] [Abstract][Full Text] [Related]
11. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
[TBL] [Abstract][Full Text] [Related]
12. Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-β1 signaling-mediated hepatocyte apoptosis.
Liu D; Wang K; Li K; Xu R; Chang X; Zhu Y; Sun P; Han X
Cell Death Dis; 2019 Jun; 10(6):458. PubMed ID: 31189885
[TBL] [Abstract][Full Text] [Related]
13. Impaired LRP6-TCF7L2 Activity Enhances Smooth Muscle Cell Plasticity and Causes Coronary Artery Disease.
Srivastava R; Zhang J; Go GW; Narayanan A; Nottoli TP; Mani A
Cell Rep; 2015 Oct; 13(4):746-759. PubMed ID: 26489464
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of non-alcoholic fatty liver disease mediated by YAP.
Chen P; Luo Q; Huang C; Gao Q; Li L; Chen J; Chen B; Liu W; Zeng W; Chen Z
Hepatol Int; 2018 Jan; 12(1):26-36. PubMed ID: 29330836
[TBL] [Abstract][Full Text] [Related]
15. Wnt/beta-catenin signaling and its modulators in nonalcoholic fatty liver diseases.
Shree Harini K; Ezhilarasan D
Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):333-345. PubMed ID: 36448560
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury.
Yang YY; Lee PC; Huang YT; Lee WP; Kuo YJ; Lee KC; Hsieh YC; Lee TY; Lin HC
Clin Sci (Lond); 2014 Jan; 126(2):163-74. PubMed ID: 23875703
[TBL] [Abstract][Full Text] [Related]
17. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
[TBL] [Abstract][Full Text] [Related]
18. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
19. Modulation of canonical Wnt signaling by the extracellular matrix component biglycan.
Berendsen AD; Fisher LW; Kilts TM; Owens RT; Robey PG; Gutkind JS; Young MF
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17022-7. PubMed ID: 21969569
[TBL] [Abstract][Full Text] [Related]
20. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
